CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule

BACKGROUND: We recently reported the relapse-free survival (RFS) significance of the combination of CD4(+) and forkhead box P3(+) (FOXP3) T-cell densities identified by immunohistochemistry in patients with stage I, II, and III colorectal cancer (CRC) who underwent curative resections. This study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagami, Yuki, Hazama, Shoichi, Suzuki, Nobuaki, Yoshida, Shin, Tomochika, Shinobu, Matsui, Hiroto, Shindo, Yoshitaro, Tokumitsu, Yukio, Matsukuma, Satoshi, Watanabe, Yusaku, Iida, Michihisa, Tsunedomi, Ryouichi, Takeda, Shigeru, Fujita, Tomonobu, Kawakami, Yutaka, Ogihara, Hiroyuki, Hamamoto, Yoshihiko, Ioka, Tatsuya, Tanabe, Tsuyoshi, Ueno, Tomio, Nagano, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578193/
https://www.ncbi.nlm.nih.gov/pubmed/36253752
http://dx.doi.org/10.1186/s12885-022-10181-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578193/
https://www.ncbi.nlm.nih.gov/pubmed/36253752
http://dx.doi.org/10.1186/s12885-022-10181-7

Ejemplares similares